Date published: 2026-4-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

CDR2 Inhibitors

CDR2 inhibitors represent a fascinating and specialized class of chemical compounds that target the CDR2 (Cerebellar Degeneration-Related protein 2) protein. CDR2 is a neuronal protein that is primarily expressed in the cerebellum and testis, and it plays a critical role in regulating various cellular functions, including signal transduction, synaptic plasticity, and the maintenance of cellular homeostasis. The inhibition of CDR2 by specific chemical agents is of significant interest because of its involvement in certain molecular pathways within the central nervous system. These inhibitors are often designed to interact with the active or binding sites of the CDR2 protein, disrupting its normal activity and thus modulating the downstream effects within the affected pathways. This modulation can lead to changes in cellular signaling and function, particularly within neurons, where CDR2 activity is most prominent. Understanding the structural and functional dynamics of CDR2 is essential for the rational design of these inhibitors, as they must precisely target the protein without affecting other crucial neuronal proteins. From a chemical perspective, CDR2 inhibitors are typically characterized by their ability to bind specifically to the CDR2 protein with high affinity. The chemical structure of these inhibitors often includes functional groups that facilitate strong interactions with the protein, such as hydrogen bonding, hydrophobic interactions, and sometimes covalent bonding. These interactions are crucial for ensuring that the inhibitor remains bound to the protein for a sufficient duration to effectively modulate its activity. Additionally, the design and synthesis of CDR2 inhibitors require a deep understanding of the protein's three-dimensional structure and the conformational changes it undergoes during interaction with various molecules. Advanced techniques such as X-ray crystallography and molecular dynamics simulations are often employed to study these interactions at the atomic level, providing insights into the optimal design of inhibitors. The ongoing research into CDR2 inhibitors not only enhances our understanding of this protein's function but also contributes to the broader field of chemical biology by highlighting the intricate relationship between chemical structure and protein function.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclophosphamide

50-18-0sc-361165
sc-361165A
sc-361165B
sc-361165C
50 mg
100 mg
500 mg
1 g
$90.00
$146.00
$469.00
$791.00
18
(1)

Alkylating agent, can modulate immune system function, potentially influencing pathways involving CDR2.

Prednisone

53-03-2sc-205816
sc-205816A
sc-205816B
1 g
5 g
25 g
$42.00
$136.00
$676.00
2
(1)

Corticosteroid, might modulate immune response and affect conditions associated with CDR2.

Azathioprine

446-86-6sc-210853D
sc-210853
sc-210853A
sc-210853B
sc-210853C
500 mg
1 g
2 g
5 g
10 g
$203.00
$176.00
$349.00
$505.00
$704.00
1
(1)

Immunosuppressant, could indirectly affect immune pathways involving CDR2.

Mycophenolate mofetil

128794-94-5sc-200971
sc-200971A
20 mg
100 mg
$37.00
$109.00
1
(1)

Inhibits inosine monophosphate dehydrogenase, may impact immune responses involving CDR2.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

Immunosuppressant, might influence immune pathways related to CDR2.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Antimetabolite and immunosuppressant, could affect pathways related to CDR2.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Immunomodulatory drug, could impact immune pathways involving CDR2.